Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.63 USD | +2.52% | +0.31% | -38.26% |
May. 09 | Cue Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 08 | Transcript : Cue Biopharma, Inc., Q4 2023 Earnings Call, Apr 08, 2024 |
Evolution of the average Target Price on Cue Biopharma, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Cue Biopharma, Inc.
Jefferies & Co. | |
Piper Sandler | |
Stifel Nicolaus | |
Oppenheimer | |
JMP Securities | |
Craig-Hallum | |
HC Wainwright |
EPS Revisions
- Stock Market
- Equities
- CUE Stock
- Consensus Cue Biopharma, Inc.